Advanced Oncotherapy plans £37.4m fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has announced a £37.4m equity fundraise to bolster its balance sheet as it moves towards completing its next generation proton beam therapy…

You must be a HM Subscriber to view this content.

Subscribe Now »